Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2023		56,142,207
Beginning balance at Dec. 31, 2023	$ 2,297,383	$ 296,483	$ (105,249)	$ 1,308,281	$ 952,124	$ (154,256)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	39,409				39,409
Other comprehensive income (loss)	(2,687)					(2,687)
Comprehensive income	36,722
Cash dividends	(12,653)				(12,653)
Issuance of common stock for stock-based compensation awards (in shares)		162,653
Issuance of common stock for stock-based compensation awards	(3,094)		5,566	(8,660)
Stock-based compensation expense	3,992			3,992
Ending balance (in shares) at Mar. 31, 2024		56,304,860
Ending balance at Mar. 31, 2024	2,322,350	$ 296,483	(99,683)	1,303,613	978,880	(156,943)
Beginning balance (in shares) at Dec. 31, 2023		56,142,207
Beginning balance at Dec. 31, 2023	2,297,383	$ 296,483	(105,249)	1,308,281	952,124	(154,256)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	150,710
Other comprehensive income (loss)	25,162
Comprehensive income	175,872
Ending balance (in shares) at Sep. 30, 2024		63,564,028
Ending balance at Sep. 30, 2024	2,658,078	$ 332,421	(97,251)	1,488,678	1,063,324	(129,094)
Beginning balance (in shares) at Mar. 31, 2024		56,304,860
Beginning balance at Mar. 31, 2024	2,322,350	$ 296,483	(99,683)	1,303,613	978,880	(156,943)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	38,846				38,846
Other comprehensive income (loss)	2,827					2,827
Comprehensive income	41,673
Cash dividends	(12,640)				(12,640)
Issuance of common stock for stock-based compensation awards (in shares)		63,064
Issuance of common stock for stock-based compensation awards	(56)		2,149	(2,205)
Stock-based compensation expense	3,374			3,374
Ending balance (in shares) at Jun. 30, 2024		56,367,924
Ending balance at Jun. 30, 2024	2,354,701	$ 296,483	(97,534)	1,304,782	1,005,086	(154,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	72,455				72,455
Other comprehensive income (loss)	25,022					25,022
Comprehensive income	97,477
Cash dividends	$ (14,217)				(14,217)
Common stock issued in public offering (in shares)	7,187,500
Common stock issued in public offering	$ 217,000	$ 35,938		181,062
Issuance of common stock for stock-based compensation awards (in shares)		8,604
Issuance of common stock for stock-based compensation awards	(156)		283	(439)
Stock-based compensation expense	3,273			3,273
Ending balance (in shares) at Sep. 30, 2024		63,564,028
Ending balance at Sep. 30, 2024	$ 2,658,078	$ 332,421	(97,251)	1,488,678	1,063,324	(129,094)
Beginning balance (in shares) at Dec. 31, 2024	63,565,690	63,565,690
Beginning balance at Dec. 31, 2024	$ 2,678,318	$ 332,421	(97,196)	1,491,847	1,093,854	(142,608)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	41,518				41,518
Other comprehensive income (loss)	20,987					20,987
Comprehensive income	62,505
Cash dividends	(14,270)				(14,270)
Issuance of common stock for stock-based compensation awards (in shares)		173,777
Issuance of common stock for stock-based compensation awards	(3,228)		5,550	(8,778)
Stock-based compensation expense	3,780			3,780
Ending balance (in shares) at Mar. 31, 2025		63,739,467
Ending balance at Mar. 31, 2025	$ 2,727,105	$ 332,421	(91,646)	1,486,849	1,121,102	(121,621)
Beginning balance (in shares) at Dec. 31, 2024	63,565,690	63,565,690
Beginning balance at Dec. 31, 2024	$ 2,678,318	$ 332,421	(97,196)	1,491,847	1,093,854	(142,608)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	102,324
Other comprehensive income (loss)	41,438
Comprehensive income	$ 143,762
Ending balance (in shares) at Sep. 30, 2025	95,020,881	95,020,881
Ending balance at Sep. 30, 2025	$ 3,825,778	$ 488,612	(90,297)	2,389,033	1,139,600	(101,170)
Beginning balance (in shares) at Mar. 31, 2025		63,739,467
Beginning balance at Mar. 31, 2025	2,727,105	$ 332,421	(91,646)	1,486,849	1,121,102	(121,621)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,018				1,018
Other comprehensive income (loss)	7,580					7,580
Comprehensive income	8,598
Cash dividends	(21,155)				(21,155)
Common stock issued in connection with an acquisition (in shares)		31,238,172
Common stock issued in connection with an acquisition	1,059,911	$ 156,191		903,720
Issuance of common stock for stock-based compensation awards (in shares)		41,672
Issuance of common stock for stock-based compensation awards	91		1,398	(1,307)
Stock-based compensation expense	4,304			4,304
Ending balance (in shares) at Jun. 30, 2025		95,019,311
Ending balance at Jun. 30, 2025	3,778,854	$ 488,612	(90,248)	2,393,566	1,100,965	(114,041)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	59,788				59,788
Other comprehensive income (loss)	12,871					12,871
Comprehensive income	72,659
Cash dividends	(21,153)				(21,153)
Measurement period adjustment related to common stock issued in connection with an acquisition	(9,090)			(9,090)
Issuance of common stock for stock-based compensation awards (in shares)		1,570
Issuance of common stock for stock-based compensation awards	(935)		(49)	(886)
Stock-based compensation expense	$ 5,443			5,443
Ending balance (in shares) at Sep. 30, 2025	95,020,881	95,020,881
Ending balance at Sep. 30, 2025	$ 3,825,778	$ 488,612	$ (90,297)	$ 2,389,033	$ 1,139,600	$ (101,170)